• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

TVM Capital Life Science Venture Capital

Investing in Life Science Innovation

  • About Us
    • Partners
  • Team
  • Senior Advisors
  • Portfolio
  • Funding Request
  • News
  • Events
  • ESG Policy
  • Contact

News

  • Home
  • About Us
  • Team
  • Senior Advisors
  • Portfolio
  • News
  • Events
  • ESG Policy
  • Contact

News · March 17, 2023

TVM Capital Life Science to participate in LSI USA ’23 Emerging Medtech Summit 2023

Company highlights key investments from its commercial-stage medtech portfolio Montreal, Canada / Munich, Germany – 17 March 2023 – TVM Capital Life Science (“TVM”), a leading international venture …

News · February 23, 2023

TVM Capital Life Science Announces Promotions to Recognize Significant Contributions of Up-and-Coming Leaders

Montreal, Canada / Munich, Germany – 23 February 2023 – TVM Capital Life Science (“TVM”), a leading international venture capital firm focused on investments in life sciences innovation, today …

News · February 21, 2023

Esperas Pharma, Inc. Announces Investment from TVM Life Science Innovation I and The Fonds de solidarité FTQ

Montréal, Québec, February 21, 2023 – Esperas Pharma, Inc. (“Esperas”), a company based in Montréal, Québec, today announced a follow-on investment by TVM Capital Life Science (“TVM”) through its fund …

News · February 1, 2023

TVM Capital Life Science announces up to USD 24 million investment in oncology company, Recurv Pharma, Inc.

Recurv is the 8th early-stage or product focused company (PFC) investment for TVM Life Science Innovation II Fund Recurv is developing novel taxane, RP-001, against solid tumors RP-001 delivered …

News · August 1, 2022

Panthera D-SAD Classic oral appliance now eligible for Medicare reimbursement

panthera

Panthera has received notification from the Pricing, Data Analysis and Coding (PDAC) contractor, following their request for a coding decision for the Panthera      D-SAD Classic oral appliance. PDAC, …

News · June 23, 2022

Kent Imaging Recognized as Most Innovative Medical Imaging Technology Developer in Canada

handheld-kent-imaging

SnapshotNIR is enabling clinicians to drive better outcomes in wound care, limb preservation, and surgery, with its diagnostic-driven imaging technology. NEWS PROVIDED BY Kent Imaging Inc. June 21, …

News · March 29, 2022

Egg Medical hatches technology to shield health care workers from radiation

The Arden Hills company has landed $13 million in financing.  By Burl Gilyard Star Tribune MARCH 27, 2022 — 2:00PM A Twin Cities medtech startup, Egg Medical Inc., is building up sales of a new …

News · March 15, 2022

Egg Medical hatches $13M VC funding

March 4, 2022 By Annette Boyle Egg Medical Inc. secured a $13 million investment from TVM Capital Life Science to solve the Humpty-Dumpty problem that plagues interventional cardiology …

News · March 3, 2022

Egg Medical, Inc., Closes on $13 million Financing

Egg Medical, Inc., Closes on $13 million Financing Arden Hills, MN (March 3rd, 2022) — Egg Medical, Inc., a medical device company commercializing technologies to reduce scatter radiation exposure …

News · February 8, 2022

CENTOGENE Announces CFO Transition and Appointment of Miguel Coego Rios as EVP Finance & Legal and Interim CFO

centogene

CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, February 08, 2022 (GLOBE NEWSWIRE – Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on generating data-driven insights to diagnose, …

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 31
  • Go to Next Page »

Primary Sidebar

Secondary Sidebar

Additional News

CENTOGENE Announces Nomination of Andreas Busch to Supervisory Board

February 1, 2022

CENTOGENE Announces USD 62 Million Aggregate Equity and Debt Financings to Support Growth Plan

February 1, 2022

CENTOGENE Announces Nomination of Kim Stratton as Chief Executive Officer

February 1, 2022

TVM Capital Life Science promotes Dr. Sascha Berger and Dr. Alain Thibault to General Partner

January 18, 2022

Syndivia and TVM Capital Life Science Announce Creation of Auricula Biosciences to Develop Innovative Therapy for Patients with K-Ras mutant malignancies

January 13, 2022

  • in

Copyright © 2023 · TVM Capital Life Science Venture Capital · ESG Disclosure · Privacy Policy · Contact